The following speakers are scheduled to present in the MASIR program:
| J. Altman (US) | Phenotypic analysis of tetramer binding cells |
| B. Autran (F) | Antigen specific T cell responses and HIV pathogenesis |
| N. Baumgarth (US) | Enumeration of B cell responses by flow cytometry |
| D. Busch (D) | Ex vivo analysis of early events during CD8+ memory T cell development using MHC multimer technologies |
| D. Douek (US) | T cell receptor recognition motifs govern immune escape by antigen mutation in acute SIV infection |
| G. Janossy (UK) | Technical developments to assess antigen-specific T cell responses in HIV and TB (co-) infections – the clinical need for discriminating rapid tests |
| F. Kern (D) | Inroads into the phenotype and differentiation pathway of M. tuberculosis specific T cells |
| R. Koup (US) | Comparison of antigen-specific responses between vaccines and natural infection |
| T. Kuus-Reichel (US) | Immune monitoring using MHC tetramers: Potential clinical applications and practical considerations |
| A. Lanzavecchia (CH) | Analysis of human B cell responses |
| P. Lee (US) | Diversity and Recognition Efficiency of T Cell Responses to Cancer |
| A. Letsch (D) | T cell monitoring during vaccination against tumor-associated antigens |
| H. Maecker (US) | CMV and HIV-specific T cells in healthy individuals and HIV progressors |
| G. Pantaleo (CH) | Antiviral memory T cell responses |
| L. Picker (US) | Analysis of T cell function in Simian Immunodeficiency Virus (SIV) infection: New approaches using polychromatic flow cytometry |
| P. Romero (CH) | Monitoring tumor antigen specific T-cell responses in cancer patients and clinical trials of peptide-based vaccination |
| S. Rowland-Jones (UK) | HIV-specific CTL: differentiation state and cytokine sec |
| A. Scheffold (D) | High-sensitivity immunofluorescence to detect specific peptide presentation at physiologically relevant quantities |
| R. Sekaly (CA) | Pathways of memory T cell development |
| A. Thomsen (DK) | Profiling the optimal anti-viral CD8+ T cell response using MHC dextramers |
| D. van Baarle (NL) | Loss of CMV specific CD4+ cytokine production and proliferative capacity during the course of HIV |
| R. Van Lier (NL) | Molecular basis of CD8+ T cell subset differentiation |
| R. Volkmer-Engert (D) | Synthetic peptides and peptide mixtures for analysis of T-cell antigen recognition |
| M. Wills (UK) | Selection of the virus-specific CD8+ T cell repertoire following Primary Human Cytomegalovirus (HCMV) infection: TCR affinity and CD45RA+ CD28 |